{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T04:14:36Z","timestamp":1768191276371,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2000,5,1]],"date-time":"2000-05-01T00:00:00Z","timestamp":957139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2000,5,1]],"date-time":"2000-05-01T00:00:00Z","timestamp":957139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Epidemiol"],"published-print":{"date-parts":[[2000,5]]},"DOI":"10.1023\/a:1007627508918","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T05:54:50Z","timestamp":1040536490000},"page":"425-432","source":"Crossref","is-referenced-by-count":13,"title":["Prognostic factors of survival of HIV-infected patients with Cytomegalovirus disease: Aquitaine Cohort, 1986\u20131997"],"prefix":"10.1007","volume":"16","author":[{"given":"C.","family":"Binquet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Saillour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-B.","family":"Rougier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Leger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Bonnal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Dabis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"Suppl1","key":"267721_CR1","first-page":"S37","volume":"10","author":"E Bowen","year":"1996","unstructured":"Bowen E, Griffth P, Davey C, Emery V, Johnson M. Lessons from the natural history of cytomegalovirus. AIDS 1996; 10(Suppl 1): S37-S41.","journal-title":"AIDS"},{"key":"267721_CR2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/jama.1997.03550040093045","volume":"278","author":"J Kaplan","year":"1997","unstructured":"Kaplan J, Masur H, Jaffe H, Holmes K. Preventing opportunistic infections in persons infected with HIV: 1997 guidelines. JAMA 1997; 278: 337-338.","journal-title":"JAMA"},{"key":"267721_CR3","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/jama.280.1.78","volume":"280","author":"C Carpenter","year":"1998","unstructured":"Carpenter C, Fischl M, Hammer S, et al. Antiretroviral therapy for HIV infection in 1998. Updated recommandations of the international AIDS-society panel. JAMA 1998; 280: 78-86.","journal-title":"JAMA"},{"key":"267721_CR4","unstructured":"Dormont J. Strat\u00e9gies d'utilisation des antir\u00e9troviraux dans l'infection par le VIH: Flammarion M\u00e9decine Sciences, Paris, 1998."},{"key":"267721_CR5","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0140-6736(98)04084-7","volume":"352","author":"BHIVA Guidelines Coordinating Committee.","year":"1998","unstructured":"BHIVA Guidelines Coordinating Committee. 1998 revision to the British HIV association guidelines for antiretroviral treatment of HIV seropositive individuals. Lancet 1998; 352: 314-316.","journal-title":"Lancet"},{"issue":"Suppl1","key":"267721_CR6","first-page":"S43","volume":"10","author":"C. Katlama","year":"1996","unstructured":"Katlama C. Consequences for the management of cytomegalovirus. AIDS 1996; 10(Suppl 1): S43-S46.","journal-title":"AIDS"},{"key":"267721_CR7","doi-asserted-by":"crossref","first-page":"126","DOI":"10.7326\/0003-4819-125-2-199607150-00009","volume":"125","author":"H Masur","year":"1996","unstructured":"Masur H, Whitcup S, Cartwright C, Polis M, Nussenblatt R. Advances in the management of AIDS-related Cytomegalovirus retinitis. Ann Intern Med 1996; 125: 126-136.","journal-title":"Ann Intern Med"},{"key":"267721_CR8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0002-9394(14)70784-6","volume":"124","author":"J Reed","year":"1997","unstructured":"Reed J, Schwab I, Gordon J, Morse L. Regression of Cytomegalovirus retinitis associated with protease-inhibitor treatment in patients with AIDS. Am J Ophtalmol 1997; 124: 199-205.","journal-title":"Am J Ophtalmol"},{"key":"267721_CR9","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0140-6736(97)04161-5","volume":"351","author":"DW Cameron","year":"1998","unstructured":"Cameron DW, Heath-Chiozzi M, Danner S, et al. Randomised placebo-controlled trial of Ritonavir in advanced HIV-1 disease. Lancet 1998; 351: 543-549.","journal-title":"Lancet"},{"issue":"Suppl2","key":"267721_CR10","first-page":"S3","volume":"9","author":"S. Danner","year":"1995","unstructured":"Danner S. Management of Cytomegalovirus disease. AIDS 1995; 9(Suppl 2): S3-S8.","journal-title":"AIDS"},{"key":"267721_CR11","unstructured":"Matheron S, Chaput S, Gerbe J, et al. Effect of protease inhibitors on the incidence of CMV retinitis in HIV-infected patients. Sixth European Conference on clinical aspects and treatment of HIV-infection. Hamburg, Germany, 1997."},{"key":"267721_CR12","first-page":"703","volume":"26","author":"C Marimoutou","year":"1997","unstructured":"Marimoutou C, Ch\u00e2ne G, Dabis F, Lacoste D, Salamon R. Human immunodeficiency virus infection and AIDS in Aquitaine. 10 years' experience of a hospital information system, 1985-1995. Presse Med 1997; 26: 703-710 (French).","journal-title":"Presse Med"},{"key":"267721_CR13","unstructured":"RNSP. Elargissement des crit\u00e8res de la cat\u00e9gorie \u201ccontamination h\u00e9t\u00e9rosexuelle\u201d dans le cadre de la surveillance du SIDA en France. Bull Epidemiol Hebd 1996; (24): 108-109."},{"key":"267721_CR14","first-page":"1","volume":"41","author":"Centers for Disease Control.","year":"1993","unstructured":"Centers for Disease Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbid Mortal Wkly Rep 1993; 41: 1-19.","journal-title":"Morbid Mortal Wkly Rep"},{"key":"267721_CR15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"D. Cox","year":"1972","unstructured":"Cox D. Regression models and life tables (with discussion). J Roy Stat Soc B 1972; 34: 187-220.","journal-title":"J Roy Stat Soc B"},{"key":"267721_CR16","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1128\/jcm.34.2.457-459.1996","volume":"34","author":"B Beck","year":"1996","unstructured":"Beck B, Boeckh M, Lepenies J, et al. High-level sensitivity of quantitative pp65 Cytomegalovirus (CMV) antigenemia assay for diagnosis of CMV disease in AIDS patients and follow-up. J Clin Microbiol 1996; 34: 457-459.","journal-title":"J Clin Microbiol"},{"key":"267721_CR17","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/00002030-199305000-00009","volume":"7","author":"E Drouet","year":"1993","unstructured":"Drouet E, Boibieux A, Michelson S, et al. Polymerase Chain Reaction detection of Cytomegalovirus DNA in peripheral blood leukocytes as a predictor of Cytomegalovirus disease in HIV-infected patients. AIDS 1993; 7: 665-668.","journal-title":"AIDS"},{"key":"267721_CR18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0163-4453(97)91644-3","volume":"35","author":"F Saillour","year":"1997","unstructured":"Saillour F, Bernard N, Ragnaud J, Morlat P, Blanchard Y, Monlun E. Incidence of Cytomegalovirus disease in the Aquitaine Cohort of HIV-infected patients: A retrospective survey, 1987-1993. J Infect 1997; 35: 155-161.","journal-title":"J Infect"},{"key":"267721_CR19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00042560-199802010-00012","volume":"17","author":"F Saillour","year":"1998","unstructured":"Saillour F, Bernard N, Dequae-Merchadou L, et al. Predictive factors of occurrence of Cytomegalovirus disease and impact on survival in the Aquitaine Cohort in France, 1985 to 1994. J Acquir Immune Defic Syndr 1998; 17: 171-178.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"267721_CR20","doi-asserted-by":"crossref","first-page":"585","DOI":"10.7326\/0003-4819-108-4-585","volume":"108","author":"M Jacobson","year":"1988","unstructured":"Jacobson M, Mills J. Serious Cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1988; 108: 585-594.","journal-title":"Ann Intern Med"},{"key":"267721_CR21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJM199201233260401","volume":"326","author":"Studies of ocular complications of AIDS Research Group in collaboration with the AIDS Clinical Trial Group.","year":"1992","unstructured":"Studies of ocular complications of AIDS Research Group in collaboration with the AIDS Clinical Trial Group. Mortality of patients with the Acquired Immunodeficiency Syndrome treated with either foscarnet or ganciclovir for Cytomegalovirus retinitis. N Engl J Med 1992; 326: 213-220.","journal-title":"N Engl J Med"},{"key":"267721_CR22","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1177\/095646249200300504","volume":"3","author":"I Cheong","year":"1992","unstructured":"Cheong I, Flegg P, Brettle R, et al. Cytomegalovirus disease in AIDS: The Edinburgh experience. Int J STD AIDS 1992; 3: 324-328.","journal-title":"Int J STD AIDS"},{"key":"267721_CR23","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/00002030-199709000-00013","volume":"11","author":"N Low","year":"1997","unstructured":"Low N, Pfluger D, Egger M. Disseminated Mycobacterium avium complex disease in the Swiss HIV Cohort Study: Increasing incidence, unchanged prognosis. AIDS 1997; 11: 1165-1171.","journal-title":"AIDS"},{"key":"267721_CR24","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3109\/00365549709035902","volume":"29","author":"M Garly","year":"1997","unstructured":"Garly M, Petersen E, Pedersen C, Lundgren J, Gerstoft J. Toxoplasmosis in Danish AIDS patients. Scand J Infect Dis 1997; 29: 597-600.","journal-title":"Scand J Infect Dis"},{"key":"267721_CR25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/oxfordjournals.aje.a009242","volume":"146","author":"J Colford","year":"1997","unstructured":"Colford J, Segal M, Tabnak F, Chen M, Sun R, Tager I. Temporal trends and factors associated with survival after Pneumocystis cariniipneumonia in California, 1983-1992. Am J Epidemiol 1997; 146: 115-127.","journal-title":"Am J Epidemiol"},{"key":"267721_CR26","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/infdis\/166.6.1223","volume":"166","author":"J Gallant","year":"1992","unstructured":"Gallant J, Moore R, Richman D, Keruly J, Chaisson R, and the Zidovudine Epidemiology Studies Group. Incidence and natural history of Cytomegalovirus disease in patients with advanced Human Immunodeficiency Virus disease treated with zidovudine. J Infect Dis 1992; 166: 1223-1227.","journal-title":"J Infect Dis"},{"key":"267721_CR27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0163-4453(91)91987-9","volume":"23","author":"B Peters","year":"1991","unstructured":"Peters B, Beck E, Anderson S, et al. Cytomegalovirus infection in AIDS. Patterns of disease, response to therapy and trends in survival. J Infect 1991; 23: 129-137.","journal-title":"J Infect"},{"key":"267721_CR28","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1212\/WNL.44.3_Part_1.507","volume":"44","author":"N Holland","year":"1994","unstructured":"Holland N, Power C, Mathews V, Glass J, Forman M, McArthur J. Cytomegalovirus encephalitis in Acquired Immunodeficiency Syndrome (AIDS). Neurology 1994; 44: 507-513.","journal-title":"Neurology"},{"key":"267721_CR29","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/clinids\/23.1.76","volume":"23","author":"M Rodriguez-Barradas","year":"1996","unstructured":"Rodriguez-Barradas M, Stool E, Musher M, et al. Diagnosing and treating Cytomegalovirus pneumonia in patients with AIDS. Clin Infect Dis 1996; 23: 76-81.","journal-title":"Clin Infect Dis"},{"key":"267721_CR30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00002030-199801000-00004","volume":"12","author":"R Chaisson","year":"1998","unstructured":"Chaisson R, Gallant J, Keruly J, Moore R. Impact of opportunistic disease on survival in patients with HIV infection. AIDS 1998; 12: 29-33.","journal-title":"AIDS"},{"key":"267721_CR31","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1258\/0956462991913033","volume":"10","author":"J Baillargeon","year":"1999","unstructured":"Baillargeon J, Borucki M, Black S, Dunn K. Determinants of survival in HIV-positive patients. Int J STD AIDS 1999; 10: 22-27.","journal-title":"Int J STD AIDS"},{"key":"267721_CR32","doi-asserted-by":"crossref","first-page":"665","DOI":"10.7326\/0003-4819-115-9-665","volume":"115","author":"A Palestine","year":"1991","unstructured":"Palestine A, Polis M, de Smet MD, et al. A randomized, controlled trial of foscarnet in the treatment of Cytomegalovirus retinitis in patients with AIDS. Ann Intern Med 1991; 115: 665-673.","journal-title":"Ann Intern Med"},{"key":"267721_CR33","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/clinids\/14.2.608-a","volume":"14","author":"W. Drew","year":"1992","unstructured":"Drew W. Cytomegalovirus infection in patients with AIDS. Clin Infect Dis 1992; 14: 608-615.","journal-title":"Clin Infect Dis"},{"key":"267721_CR34","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/infdis\/172.1.225","volume":"172","author":"L Kaiser","year":"1995","unstructured":"Kaiser L, Perrin L, Hirschel B, et al. Foscarnet decreases Human Immunodeficiency Virus RNA. J Infect Dis 1995; 172: 225-227.","journal-title":"J Infect Dis"},{"key":"267721_CR35","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1089\/aid.1994.10.917","volume":"10","author":"M. Jacobson","year":"1994","unstructured":"Jacobson M. Current management of Cytomegalovirus disease in patients with AIDS. AIDS Res Hum Retroviruses 1994; 10: 917-923.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"267721_CR36","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/00042560-199808010-00007","volume":"18","author":"R Spira","year":"1998","unstructured":"Spira R, Marimoutou C, Binquet C, Lacoste D, Dabis F. Rapid change in the use of antiretroviral agents and improvement in a population of HIV-infected patients: France 1995 to 1997. J Acquir Immun Defic Syndr 1998; 18: 358-364.","journal-title":"J Acquir Immun Defic Syndr"},{"key":"267721_CR37","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJM199709113371101","volume":"337","author":"SM Hammer","year":"1997","unstructured":"Hammer SM, Squires KE, Hughes MD, Grimes JM, Demeter LM, Currier JS. A controlled trial of two nucleoside analogues plus Indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimetre or less. N Engl J Med 1997; 337: 725-733.","journal-title":"N Engl J Med"},{"key":"267721_CR38","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/00002030-199806000-00010","volume":"12","author":"JC Walsh","year":"1998","unstructured":"Walsh JC, Jones CD, Barnes EA, Gazzard BG, Mitchell SM. Increasing survival in AIDS patients with Cytomegalovirus retinis treated with combination an-tiretroviral therapy including HIV protease inhibitors. AIDS 1998; 12: 613-618.","journal-title":"AIDS"},{"key":"267721_CR39","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1086\/314943","volume":"180","author":"C O'Sullivan","year":"1999","unstructured":"O'Sullivan C, Drew W, McMullen D, et al. Decrease of Cytomegalovirus replication in human immunodeficiency virus infected-patients after treatment with highly active antiretroviral therapy. J Infect Dis 1999; 180: 847-849.","journal-title":"J Infect Dis"},{"key":"267721_CR40","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nm0898-953","volume":"4","author":"K Komanduri","year":"1998","unstructured":"Komanduri K, Viswanathan M, Wieder E, et al. Restoration of Cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1. Nat Med 1998; 4: 953-956.","journal-title":"Nat Med"},{"key":"267721_CR41","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1086\/515281","volume":"177","author":"J MacDonald","year":"1998","unstructured":"MacDonald J, Torriani F, Morse L, Karavellas M, Reed J, Freeman W. Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy. J Infect Dis 1998; 177: 1182-1187.","journal-title":"J Infect Dis"}],"container-title":["European Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1007627508918.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1007627508918\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1007627508918.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T05:03:56Z","timestamp":1753851836000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1007627508918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,5]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2000,5]]}},"alternative-id":["267721"],"URL":"https:\/\/doi.org\/10.1023\/a:1007627508918","relation":{},"ISSN":["0393-2990","1573-7284"],"issn-type":[{"value":"0393-2990","type":"print"},{"value":"1573-7284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,5]]}}}